Education · Sublingual Delivery

How Sublingual Peptide Strips Work: The Delivery Science, Honestly Explained

How sublingual peptides work: mouth anatomy, first-pass metabolism, molecule sizes, and what the evidence shows so far.

LAST REVIEWED 2026-08-16READ TIME ~7 MINEDUCATIONAL — NOT A PRODUCT PAGEBY NICK PETRUCCI, FOUNDER

Short answer: Sublingual peptide strips are thin dissolving films placed under the tongue. The tissue there is thin, blood-rich, and drains in a way that skips the digestive gauntlet — so part of the active can absorb directly toward circulation while the rest is swallowed. It is a real, established pharmaceutical format.

This is the page we built to be the reference for the category — the one every delivery-science article on this site links back to. The format is genuinely clever, the anatomy genuinely favors it, and once you see how it works, the appeal is obvious. Here's the whole story.

What an oral dissolving film actually is

The strip format isn't a supplement-industry invention. Oral dissolving films (ODFs) are an established pharmaceutical dosage form — thin, flexible sheets, typically built on a water-soluble polymer base, that hydrate and dissolve against the moist tissue of the mouth. The format has been used in regulated drug products for roughly two decades. This is grown-up delivery technology, miniaturized into something that looks like a breath-freshener strip.

The strips we carry use pullulan as the film base — a neutral, water-soluble polysaccharide produced by fermentation, widely used in edible films and capsule shells. The film holds a measured amount of active ingredient in a uniform matrix: each BPC-157 sublingual strip contains 500 mcg, and each NAD+ strip contains 100 mg. The film dissolves in contact with saliva in seconds — no water, no chewing, no mixing.

The anatomy: why under the tongue is prime real estate

Not all mouth tissue is equal. The floor of the mouth — the sublingual region — is lined with some of the thinnest, non-keratinized epithelium in the oral cavity, sitting directly over a dense network of capillaries. The inner cheek (buccal) mucosa is thicker and somewhat less permeable. Both are used for transmucosal drug delivery; sublingual is the more permeable of the two.

The key anatomical fact is where that blood supply goes: vessels under the tongue drain toward the jugular vein and into general circulation. A compound that crosses this tissue enters the bloodstream without first passing through the liver or the digestive tract — which brings us to the main event.

First-pass metabolism: the gauntlet strips skip

Swallow a capsule and its contents take the long road: stomach acid, digestive enzymes, absorption through the intestinal wall, then straight into the portal vein — which routes everything through the liver before it reaches the rest of you. The gut and liver together can chemically dismantle a large fraction of a swallowed compound before it ever circulates. That's first-pass metabolism.

For peptides, the gut leg is especially brutal: peptides are chains of amino acids, and digestion is specifically built to break chains of amino acids apart. This is why nearly all peptide research has historically used injections. Anything that genuinely absorbs through the mouth tissue skips that gauntlet for the absorbed fraction. That's the real, legitimate premise of sublingual delivery — and it's why the format has carried regulated drug products for twenty years.

Molecular size: the gatekeeper, honestly explained

Whether a molecule crosses the oral mucosa passively depends heavily on its size and charge. Smaller, uncharged molecules cross most readily. Some real numbers for context:

Niacin: ~123 Da — small; crosses mucosa well.
Nicotinamide riboside (NR): ~255–290 Da — borderline-small.
NMN: ~334 Da — borderline.
Intact NAD+: ~663 Da and electrically charged — the challenging case; it doesn't survive the gut intact either. This is why the NAD-precursor literature leans on NR and NMN, which are orally bioavailable and have raised blood NAD+ in human trials [published human data].
BPC-157: ~1,419 Da (15 amino acids) — large by mucosal standards, but famous for one reason: it's stable in gastric fluid rather than being instantly digested [preclinical evidence].

The dual-route advantage nobody leads with

Here's what actually happens when you hold a strip under your tongue: some fraction absorbs through the mucosa while the film dissolves; the remainder mixes with saliva and is swallowed. Every sublingual product works this way — and for the right molecules, that's a feature, not a bug:

For BPC-157, the swallowed fraction isn't wasted. Because the peptide is gastric-stable, oral and GI-tract activity is exactly where much of the animal research has focused — including studies giving it in drinking water [preclinical evidence]. The dual route plays directly to this molecule's documented strengths: mouth contact first, gut stability second.
For large, digestion-fragile peptides, mouth dwell time does the heavy lifting — the thin sublingual tissue is the opportunity.
For precursors like NR and NMN, the swallowed route is already proven in human trials [published human data].

What's in the film besides the active

The excipient panel across the line is a consistent film base: pullulan (the dissolving polymer), β-cyclodextrin (a ring-shaped carbohydrate used in food and pharma formulations to hold and carry other molecules), sunflower lecithin (a phospholipid used as an emulsifier and liposomal building block), plus glycerin, gums, citric acid, flavor extracts, and natural colorants depending on the SKU.

Cyclodextrins and phospholipids belong to a class of formulation ingredients studied in delivery science because they can influence how actives behave at a membrane. We mention them because they're on the label and they're interesting — not to attach an absorption claim to them.

How the strips are used

Per the label, the pattern is simple: place one strip under the tongue, let it dissolve fully, then swallow what remains [brand claim — unverified]. The "hold, then swallow" sequence exists precisely because of the dual-route reality — the hold maximizes contact time with the sublingual tissue; the swallow captures the rest. This is a description of labeled use, not dosing guidance; anything beyond the label is a conversation for your healthcare provider.

The honest context

Here's the passage that doesn't help us sell, kept anyway: no published, peer-reviewed human pharmacokinetic study exists for these specific strip products — nothing has measured exactly how much of each active reaches blood, through which route, at what rate. The vast majority of peptide research used injections, and the "80–92% bioavailability" figures floating around reseller sites trace to marketing copy, not any published study we can find [brand claim — unverified]. If your provider recommends an injectable protocol for a specific reason, a strip is not a proven substitute. What stands on solid ground: the ODF format is established pharmaceutical technology, the sublingual anatomy is favorable and well documented, and for gastric-stable molecules like BPC-157 the dual route is genuinely well matched to the science.

The bottom line

Sublingual strips stand on two decades of established pharmaceutical film technology, anatomy that genuinely favors mouth absorption, and a dual-route design that plays to the strengths of the catalog's best-documented molecules. No water, no needles, no clinic — a measured strip that dissolves in seconds and goes anywhere your day goes. That's why this format keeps growing, and why so many users report it's the first delivery method they've actually stuck with.

---

Explore this cluster

The rest of the delivery-science file — the mechanism, the excipients, the format comparisons and the honest unknowns.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

Frequently asked

how sublingual peptides work questions, answered straight

Do sublingual peptides work as well as injections?

Injections put a known dose directly into tissue; strips deliver a split between mouth absorption and swallowing, and head-to-head equivalence hasn't been published. What strips deliver instead is needle-free convenience and a format people actually stick with — which is why the category keeps growing.

Is sublingual the same as oral?

No. Sublingual aims for absorption through the mouth tissue into local blood vessels, bypassing digestion and the liver's first pass. Oral means swallowing, which routes everything through the gut and liver. In practice, strips are dual-route: part sublingual, part swallowed.

How long should you hold a strip under your tongue?

The label directs you to let the strip fully dissolve under the tongue before swallowing. That's a usage description, not dosing advice — follow the product label and your provider's guidance.

Is there proof these strips absorb?

The format (ODF) and the anatomy are well established; product-specific human pharmacokinetic data hasn't been published yet. We say so plainly because you deserve the real picture — and the picture underneath it is a legitimate delivery technology with two decades of regulated use.

Keep reading